American Portfolios Advisors Tarsus Pharmaceuticals, Inc. Transaction History
American Portfolios Advisors
- $2.36 Trillion
- Q3 2022
A detailed history of American Portfolios Advisors transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 39 shares of TARS stock, worth $1,748. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39Holding current value
$1,748% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TARS
# of Institutions
170Shares Held
43.3MCall Options Held
484KPut Options Held
4.1K-
Rtw Investments, LP New York, NY3.41MShares$153 Million1.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$146 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.44MShares$109 Million2.89% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$101 Million6.32% of portfolio
-
Morgan Stanley New York, NY2.21MShares$99 Million0.01% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.2B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...